Telephone sharing button Contact Us linkedin sharing button LinkedIn wechat sharing button YouTube wechat sharing button Twitter mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button
>

Discovery

Integrated Discovery Platform
From Concept to IND

Discovery Overview


WuXi Biologics offers industry-leading expertise, state-of-the-art facilities, and multiple antibody generation technology platforms for the discovery of novel monoclonal, bispecific and multispecific antibodies, immunocytokines and other biologics. We tailor solutions to best suit your technical and budget requirements and to ensure you achieve your key drug development milestones. Our antibody discovery team comprises about 400 highly-trained scientists for the generation, selection, optimization, and characterization of antibodies or other biologic molecules utilizing advanced in vitro and in vivo approaches. Based on your R&D goals, we customize a program that will advance your project from concept to IND filing. We also offer modular service and flexible business models. 

 

 

WuXi Biologics enable clients to advance projects

from concept to commercialization

 

Integrated End-To-End Discovery Services

Target (Concept)

Lead Optimization & Characterization

IND Filing Support

Customized Featured Services

The Choice is Yours

mAb Discovery

Bispecific Antibody

Lead Optimization

In Vitro Characterizations

Track Record of Discovery Services

~
400

Scientists

15
+

Countries and Regions Served

200
+

Integrated Discovery Projects

20
+

Clinical Stage

2

Approved

Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?